Although this study suggests a disease-promoting role for NEK2 in ovarian cancer, the KMPlot data demonstrate a conflicting view by showing a beneficial hazard ratio for patients with higher NEK2 levels. The gene discussed is NEK2; the disease is ovarian carcinoma.